Health Payer Intelligence September 20, 2022
As generics moved to higher tiers, out-of-pocket healthcare spending for generics increased for patients.
While negotiated drug prices dropped, out-of-pocket healthcare spending on generic prescription drugs increased for patients as generics moved from Tier 1 to tiers typically dedicated to brand drugs, according to a study from Avalere.
The researchers used Medicare Part D data from CMS for both Medicare Advantage prescription drug plans and standalone Medicare Part D plans as well as the CMS Medicare Part D Drug Dashboard. The drugs that the study analyzed were on the market in 2011, 2015, and 2019 to capture change over time.
“Generally, generic drugs placed on higher formulary tiers have higher cost-sharing requirements than those placed on lower formulary tiers,...
Today's Sponsors
Today's Sponsor